Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients.
Quillien V, Lavenu A, Ducray F, Meyronet D, Chinot O, Fina F, Sanson M, Carpentier C, Karayan-Tapon L, Rivet P, Entz-Werle N, Legrain M, Zalcman EL, Levallet G, Escande F, Ramirez C, Chiforeanu D, Vauleon E, Figarella-Branger D. Quillien V, et al. Cancer Biomark. 2017 Dec 6;20(4):435-441. doi: 10.3233/CBM-170191. Cancer Biomark. 2017. PMID: 28800313 Free article.
Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods.
Karayan-Tapon L, Quillien V, Guilhot J, Wager M, Fromont G, Saikali S, Etcheverry A, Hamlat A, Loussouarn D, Campion L, Campone M, Vallette FM, Gratas-Rabbia-Ré C. Karayan-Tapon L, et al. Among authors: quillien v. J Neurooncol. 2010 May;97(3):311-22. doi: 10.1007/s11060-009-0031-1. Epub 2009 Oct 20. J Neurooncol. 2010. PMID: 19841865
Overview of cellular immunotherapy for patients with glioblastoma.
Vauleon E, Avril T, Collet B, Mosser J, Quillien V. Vauleon E, et al. Among authors: quillien v. Clin Dev Immunol. 2010;2010:689171. doi: 10.1155/2010/689171. Epub 2010 Oct 4. Clin Dev Immunol. 2010. PMID: 20953324 Free PMC article. Review.
DNA methylation in glioblastoma: impact on gene expression and clinical outcome.
Etcheverry A, Aubry M, de Tayrac M, Vauleon E, Boniface R, Guenot F, Saikali S, Hamlat A, Riffaud L, Menei P, Quillien V, Mosser J. Etcheverry A, et al. Among authors: quillien v. BMC Genomics. 2010 Dec 14;11:701. doi: 10.1186/1471-2164-11-701. BMC Genomics. 2010. PMID: 21156036 Free PMC article.
[MGMT analysis in gliomas].
Quillien V, Vauléon E, Saikali S, Lesimple T, Hamlat A, Etcheverry A, Mosser J. Quillien V, et al. Bull Cancer. 2011 Mar;98(3):291-303. doi: 10.1684/bdc.2011.1332. Bull Cancer. 2011. PMID: 21459716 Free article. Review. French.
Mechanisms of immunomodulation in human glioblastoma.
Avril T, Vauleon E, Tanguy-Royer S, Mosser J, Quillien V. Avril T, et al. Among authors: quillien v. Immunotherapy. 2011 Apr;3(4 Suppl):42-4. doi: 10.2217/imt.11.39. Immunotherapy. 2011. PMID: 21524170 Review.
Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients.
Quillien V, Lavenu A, Karayan-Tapon L, Carpentier C, Labussière M, Lesimple T, Chinot O, Wager M, Honnorat J, Saikali S, Fina F, Sanson M, Figarella-Branger D. Quillien V, et al. Cancer. 2012 Sep 1;118(17):4201-11. doi: 10.1002/cncr.27392. Epub 2012 Jan 31. Cancer. 2012. PMID: 22294349 Free article.
93 results